ISPOR Announces New Editor-in-Chief for Value in Health, Nancy J. Devlin, PhD

Dec 18, 2023

ISPOR announced the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health.

Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Dec 11, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions

ISPOR Announces 2023 Health Economics and Outcomes Research Award Honorees

Oct 3, 2023

ISPOR announced the recipients of its 2023 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

ISPOR Europe 2023 Plenaries and Speakers Announced

Sep 25, 2023

ISPOR announced the plenary sessions and speakers for ISPOR Europe 2023. The conference is scheduled for 12-15 November in Copenhagen, Denmark with the theme, “Health Economics and Outcomes Research at the Nexus of Policy and Science.”

Proposed Drug Pricing Policy Would Save Medicare Between $1 Billion and $2.1 Billion Annually

Sep 5, 2023

Value in Health, the official journal of ISPOR, announced the publication of a report that identifies expensive Medicare Part B drugs with low added therapeutic benefit and models a reimbursement policy for them based on domestic reference pricing.

ISPOR Announces New Chief Science Officer

Aug 28, 2023

ISPOR announced that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.

Global Multistakeholder Panel Provides First-of-its-Kind Guidance on Assessing the Value of Biosimilar Drugs

Aug 15, 2023

Value in Health published a new ISPOR Report that provides an overview of gaps and challenges in the value assessment of biosimilars and identifying potential approaches to address them. The report was published in the August 2023 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×